Zoetis Inc Class A (ZTS)

Industry Drug Manufacturers - Specialty & Generic


This stock can be held in an Investment ISA and an Investment Account
Sell

$77.30

Buy

$77.87

arrow-up$2.32 (+3.09%)

Prices updated at 29 Aug 2026, 00:57 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dog ...

Most recent dividend payment

0.530
Cash Dividend
20 Jul 2026
20 May 2026
20 Jul 2026
01 Sep 2026

Total dividend yield

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20261.5900-
20252.00000.16
20241.72800.15
20231.50000.15
20221.30000.30
20211.00000.25
20200.80000.22
20190.65600.30
20180.50400.20
20170.42000.11

Total dividend yield data table

Dividend yield (%)Buyback yield (%)
20262.7010.64
20251.593.23
20241.062.11
20230.761.39
20220.892.03
20210.410.47
20200.480.54
20190.500.95
20180.591.64
20170.581.28

Dividend per share

% of earnings paid to shareholders

Dividend per share data table

YearDividend per share
20261.5900
20252.0000
20241.7280
20231.5000
20221.3000
20211.0000
20200.8000
20190.6560
20180.5040
20170.4200

% of earnings paid to shareholders data table

YearPayout ratio (%)
202633.28
202532.53
202431.41
202329.53
202227.97
202122.89
202022.02
201920.46
201820.29
201721.58
Latest Financial Report as of 28 Aug 2026
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser.

© Copyright 2026 Morningstar. All rights reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

The ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.